Objective Coronavirus disease 2019 (COVID-19), a novel viral disease originating from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease with dramatic morbidity and mortality globally. In this review, we aim to discuss the current evidence showing that the Imam Kazem drug, a natural compound that comprises Foeniculum vulgare, Terminalia chebula, Pistacia lentiscus, and red sugar, may be a therapeutic candidate in the fight against COVID-19 infection. Methods This literature review was performed by searching related words, including “ Imam Kazem drug,” “ Foeniculum vulgare,” “ Terminalia chebula,” “ Pistacia lentiscus,” “ Red sugar,” “Natural compounds,” “Traditional medicine,” “Coronaviruses,” “Antiviral,” “COVID-19,” “SARS-CoV-2,” in different databases like Google Scholar, Scopus, PubMed, Web of Science, and Scientific Information Databases until 2023. Results The current documents underscore that the Imam Kazem drug may be safe and effective against COVID-19. This natural compound, thanks to its constituents, may affect the pathogenic occurrence related to the disease, such as attenuating oxidative stress and inflammation-associated occurrences by different mechanisms, like scavenging free radicals, enhancing the function of antioxidant enzymes, and attenuating cytokine storm. Moreover, the Imam Kazem drug can exert its antiviral ability mainly by suppressing viral replication and blocking glycosaminoglycan binding sites. However, more preclinical and clinical evidence is required to support these results. Conclusion Imam Kazem drug may have a therapeutic capacity for patients with COVID-19 infection.
Read full abstract